Eargo, Inc.
EARDelisted Feb 16, 2024- Industry
- Orthopedic, Prosthetic & Surgical Appliances & Supplies
- SEC CIK
- 0001719395
Eargo, Inc. was delisted on Feb 16, 2024; its insiders filed their last Form 4 on Feb 20, 2024; 23 institutions reported holding it in 13F filings for Q4 2023, worth $44.2M in total; no superinvestor held it.
Q2 2023 vs. Q1 2023
How the institutions holding Eargo, Inc. changed between Q1 2023 and Q2 2023.
All holders in Q2 2023All holders in Q1 2023
| Measure | Q1 2023 | Q2 2023 | Change |
|---|---|---|---|
| Holders | 24 | 19 | −5 |
| Shares | 16.8M | 16.7M | −112.8K (−0.7%) |
| Value | $78.7M | $82.4M | +$3.65M (+4.6%) |
New holders (2)
Institutions that held Eargo, Inc. at the end of Q2 2023 but not at the end of Q1 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Byrne Asset Management LLC | 4,000 | $20.0K | 0.01% |
| UBS Group AG | 463 | $2.28K | 0.00% |
Sold out (7)
Institutions that held Eargo, Inc. at the end of Q1 2023 and filed for Q2 2023 without it.
| Institution | Shares, Q1 2023 | Value, Q1 2023 |
|---|---|---|
| Susquehanna International Group, LLP | 25,057 | $117.3K |
| Bank of New York Mellon Corp | 19,354 | $90.6K |
| Federation des caisses Desjardins du Quebec | 147 | $688 |
| Federated Hermes, Inc. | 101 | $473 |
| JPMorgan Chase & Co | 82 | $384 |
| Baillie Gifford & Co | 13 | $61 |
| Tower Research Capital LLC (TRC) | 79 | $0 |